Exploring The Nipah Virus: Insights Into Pathogenesis And Therapeutic Approaches.

Nipah virus (NiV), classified as a biosafety level-4 (BSL-4) pathogen, poses a significant challenge in the field of infectious diseases, as its capacity to move between animals and humans raises serious global health concerns. This analysis explores the historical progression of NiV outbreaks, examining its effects on communities globally. This study investigates the emergence and epidemiology of the virus, focussing on its transmission dynamics and the significant impact it has had on affected regions. The neurological sequelae observed in survivors highlight the critical need for thorough care strategies. The exploration of molecular targets for antiviral drug development and current vaccine initiatives is undertaken, in conjunction with computational strategies in drug design. Targeting Ephrin-B2 and Ephrin-B3 presents a promising approach in NiV therapeutics, providing specificity and the potential for broad-spectrum activity. [ABSTRACT FROM AUTHOR]